检索结果 - Steven J. Charlton

Refine Results
  1. 1
    Agonist efficacy and receptor desensitization: from partial truths to a fuller picture

    Agonist efficacy and receptor desensitization: from partial truths to a fuller picture 由 Steven J. Charlton

    出版 2009
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Long‐lasting target binding and rebinding as mechanisms to prolong <i>in vivo</i> drug action

    Long‐lasting target binding and rebinding as mechanisms to prolong <i>in vivo</i> drug action 由 Georges Vauquelin, Steven J. Charlton

    出版 2010
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands

    Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands 由 Georges Vauquelin, Steven J. Charlton

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays

    Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays 由 Steven J. Charlton, Georges Vauquelin

    出版 2010
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Slow receptor dissociation is not a key factor in the duration of action of inhaled long‐acting β<sub>2</sub>‐adrenoceptor agonists

    Slow receptor dissociation is not a key factor in the duration of action of inhaled long‐acting β<sub>2</sub>‐adrenoceptor agonists 由 David A. Sykes, Steven J. Charlton

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M<sub>3</sub>receptor

    Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M<sub>3</sub>receptor 由 Mark R. Dowling, Steven J. Charlton

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?

    Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path? 由 Martin C. Michel, Steven J. Charlton

    出版 2018
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Miniaturized Receptor Binding Assays: Complications Arising from Ligand Depletion

    Miniaturized Receptor Binding Assays: Complications Arising from Ligand Depletion 由 Clare M. Scaramellini Carter, Juliet Leighton-Davies, Steven J. Charlton

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Evidence that P2Y<sub>4</sub> nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP

    Evidence that P2Y<sub>4</sub> nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP 由 Simon Harper, Tania E. Webb, Steven J. Charlton, Leong L. Ng, Michael R. Boarder

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    A common intracellular allosteric binding site for antagonists of the CXCR2 receptor

    A common intracellular allosteric binding site for antagonists of the CXCR2 receptor 由 Karolina Salchow, ME Bond, SC Evans, NJ Press, Steven J. Charlton, PA Hunt, ME Bradley

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    PPADS and suramin as antagonists at cloned P<sub>2Y</sub>‐ and P<sub>2U</sub>‐purinoceptors

    PPADS and suramin as antagonists at cloned P<sub>2Y</sub>‐ and P<sub>2U</sub>‐purinoceptors 由 Steven J. Charlton, Colin A. Brown, Gary A. Weisman, John T. Turner, Laurie Erb, Michael R. Boarder

    出版 1996
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Cloned and transfected P2Y<sub>4</sub> receptors: characterization of a suramin and PPADS‐insensitive response to UTP

    Cloned and transfected P2Y<sub>4</sub> receptors: characterization of a suramin and PPADS‐insensitive response to UTP 由 Steven J. Charlton, Colin A. Brown, Gary A. Weisman, John T. Turner, Laurie Erb, Michael R. Boarder

    出版 1996
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

    The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease 由 Philippa R Dale, Hana Černecká, Martina Schmidt, Mark R. Dowling, Steven J. Charlton, Michael Pieper, Martin C. Michel

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors

    Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors 由 David A. Sykes, Holly Moore, Lisa A. Stott, Nicholas D. Holliday, Jonathan A. Javitch, J. Robert Lane, Steven J. Charlton

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

    Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy 由 David A. Sykes, Michelle Bradley, Darren Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois, Steven J. Charlton

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization

    Investigating the molecular mechanisms through which <scp>FTY</scp>720‐<scp>P</scp> causes persistent <scp>S1P<sub>1</sub></scp> receptor internalization 由 David A. Sykes, Darren Riddy, Craig Stamp, Michelle Bradley, Neil McGuiness, Afrah Sattikar, Danilo Guerini, Inês S. Rodrigues, Albrecht Glaenzel, Mark R. Dowling, Florian Müllershausen, Steven J. Charlton

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35

    The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35 由 Amanda E. Mackenzie, Gianluigi Caltabiano, Toby Kent, Laura Jenkins, Jennifer E. McCallum, Brian D. Hudson, Stuart A. Nicklin, Lindsay Fawcett, Rachel Markwick, Steven J. Charlton, Graeme Milligan

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization

    μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization 由 Jamie McPherson, Guadalupe Rivero, Myma Baptist, Javier Llorente, Suleiman Al‐Sabah, Cornelius Krasel, William L. Dewey, Christopher Bailey, Elizabeth M. Rosethorne, Steven J. Charlton, Graeme Henderson, Eamonn Kelly

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor

    Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor 由 Guadalupe Rivero, Javier Llorente, Jamie McPherson, Alex Cooke, Stuart J. Mundell, Craig A. McArdle, Elizabeth M. Rosethorne, Steven J. Charlton, Cornelius Krasel, Christopher Bailey, Graeme Henderson, Eamonn Kelly

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Mass spectrometry captures biased signalling and allosteric modulation of a G-protein-coupled receptor

    Mass spectrometry captures biased signalling and allosteric modulation of a G-protein-coupled receptor 由 Hsin‐Yung Yen, Idlir Liko, Wanling Song, Parth Kapoor, Fernando Almeida, Joanna Toporowska, Karolina Gherbi, Jonathan T. S. Hopper, Steven J. Charlton, Argyris Politis, Mark S.P. Sansom, Ali Jazayeri, Carol V. Robinson

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: